Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep;4(3):123-30.
doi: 10.1097/ADM.0b013e3181db6b67.

Screening and brief intervention for unhealthy drug use in primary care settings: randomized clinical trials are needed

Richard Saitz  1 , Daniel P Alford, Judith Bernstein, Debbie M Cheng, Jeffrey Samet, Tibor Palfai
Affiliations

Screening and brief intervention for unhealthy drug use in primary care settings: randomized clinical trials are needed

Richard Saitz et al. J Addict Med. 2010 Sep.

Abstract

The efficacy of screening and brief intervention (SBI) for drug use in primary care patients is largely unknown. Because of this lack of evidence, US professional organizations do not recommend it. Yet, a strong theoretical case can be made for drug SBI. Drug use is common and associated with numerous health consequences, patients usually do not seek help for drug abuse and dependence, and SBI has proven efficacy for unhealthy alcohol use. On the other hand, the diversity of drugs of abuse and the high prevalence of abuse and dependence among those who use them raise concerns that drug SBI may have limited or no efficacy. Federal efforts to disseminate SBI for drug use are underway, and reimbursement codes to compensate clinicians for these activities have been developed. However, the discrepancies between science and policy developments underscore the need for evidence-based research regarding the efficacy of SBI for drug use. This article discusses the rationale for drug SBI and existing research on its potential to improve drug-use outcomes and makes the argument that randomized controlled trials to determine its efficacy are urgently needed to bridge the gap between research, policy, and clinical practice.

Keywords: addiction; brief intervention; drug screening; drug use; primary care.

PubMed Disclaimer

References

    1. Compton WM, Thomas YF, Stinson FS, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007;64:566–576. - PubMed
    1. Substance Abuse and Mental Health Services Administration. Results from the 2006 National Survey on Drug Use and Health: National Findings. Rockville, MD: Office of Applied Studies; 2007. (NSDUH Series H-32). DHHS Publication No. SMA 07-4293.
    1. Office of National Drug Control Policy. The Economic Costs of Drug Abuse in the United States, 1992-2002. Washington, DC: Executive Office of the President; 2004. Publication No. 207303.
    1. McLellan AT. Have we evaluated addiction treatment correctly? Implications from a chronic care perspective. Addiction. 2002;97:249–252. - PubMed
    1. McLellan AT, Lewis DC, O'Brien CP, et al. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284:1689–1695. - PubMed